Search
Cerus Corp
CERSAdd to Watchlist
2.700USD
+0.130+5.06%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
540.85MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Cerus Corp is 8.67, ranking 17 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 5.00, with a high of 5.00 and a low of 4.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
4.500
Target Price
+66.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Cerus Corp
CERS
3
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cerus Corp's expected revenue for the next quarter?
Cerus Corp's expected revenue is 60.93M.
What is Cerus Corp's price target?
Analysts forecast that Cerus Corp's price target is USD 5.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 4.00.
How have Cerus CorpCERS's recent earnings per share performed?
The market expectation was USD -0.01, while Cerus CorpCERS's earnings per share (EPS) for the previous quarter was USD -0.01. EPS for the next quarter is expected at USD -0.02.
What is the analyst rating for Cerus Corp?
Based on the ratings of Cerus Corp's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
